摘要
Background
Drug-induced hypothermia and hypometabolism are candidate therapies for acute ischemic stroke. The chlorpromazine-promethazine combination (C+P) has been shown to induce hypothermia and hypometabolism in mice and rhesus monkeys, and proved safe in a phase 1 trial, yet the contribution of each component has never been resolved. We therefore deconstructed the combination and asked whether protection is attributable to a shared metabolic program or to separable mechanisms.
Methods
Adult mice underwent middle cerebral artery occlusion by suture insertion and received chlorpromazine alone (C), promethazine alone (P), C+P, or vehicle. Each drug was dosed at 11.1 mg/kg, identical to its respective dose within the combination. Infarct volume and neurological deficit were assessed; core temperature was recorded; brain tissue was profiled by targeted metabolomics and metabolic flux; and global protein lysine lactylation was measured by immunoblotting.
Results
All three treatments reduced infarct volume, in the rank order C+P > C > P. Both C+P and C significantly reduced whole body metabolic rate while P did not. Each drug displaced exactly one glycolytic step, and the steps differed: P at hexokinase (mass-action ratio 0.21, P = 0.007) and C at phosphofructokinase-1 (0.65, P = 0.022). Only C contracted the upper TCA pool (citrate 0.82, cis-aconitate 0.66, isocitrate 0.77; P = 0.012), whereas P left TCA unchanged (P = 0.87), and only C lowered body temperature. Also, C and C+P lowered global lactylation but not by P. The combination's cerebral metabolic profile correlated with C alone (r = 0.897) but not with P (r = -0.121).
Conclusions
Promethazine alone restricts glycolytic entry without suppressing systemic metabolism and was the least protective. Chlorpromazine and the combination were both more protective and closed the mitochondrial exit as well as the entry gate. Hypometabolism therefore appears to require coordinated restriction of both gates, rather than any single cerebral metabolite profile.
